Blackstone Emerges As Likely Buyer Of Takeda OTC Business
Up To $2.8bn Deal Soon?
Private equity group Blackstone is reportedly near a deal to acquire Takeda's consumer health business in Japan for up to $2.8bn as the Japanese pharma firm continues to shed non-core assets.
